Fund shareholders of Satellos Bioscience, Inc.
ISIN CA80401L8033 · Canada · LEI 529900EN243BZ5QC9N39
- Fund shareholders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 3.5M $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 343,237 | 3.4M $ | 0.30 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,907 | 86.9K $ | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.30 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | +1 | 355,144 | +3.5 % |
| 2026Q2 | 1 | 0 | 343,237 | -70.5 % |
| 2026Q1 | 1 | 1,161,960 |
Cite this page
Titelia. "Fund shareholders of Satellos Bioscience, Inc.". https://titelia.com/en/stocks/satellos-bioscience-inc-CA80401L8033